How should azithromycin be dosed and what are its contraindications?

Azithromycin Dosing and Contraindications

Azithromycin is contraindicated only in patients with a history of hypersensitivity to any macrolide antibiotic, and dosing varies significantly by indication, age, and clinical context.

Absolute Contraindications

The primary contraindication is hypersensitivity to any macrolide agent 1. This is straightforward—any prior allergic reaction to azithromycin, erythromycin, clarithromycin, or other macrolides precludes use.

Key Precautions and Relative Contraindications

Cardiac Considerations

• QTc prolongation >450 ms (men) or >470 ms (women) is considered a contraindication when initiating long-term macrolide therapy 2
• Obtain baseline ECG before starting chronic azithromycin therapy
• Monitor patients on drugs that prolong QT interval (digoxin, triazolam, ergot alkaloids) 1

Hepatic Impairment

Use with caution in patients with impaired hepatic function 1. While no specific dose adjustment guidelines exist (pharmacokinetics haven't been established in hepatic impairment), baseline liver function tests should be obtained 2.

Drug Interactions

• Do NOT co-administer aluminum- or magnesium-containing antacids simultaneously—they reduce azithromycin absorption 1
• Space antacids and azithromycin by several hours
• Monitor closely when used with cytochrome P450-metabolized drugs 1

Age-Specific Dosing

Infants <1 Month (Neonates)

For pertussis treatment/prophylaxis: 10 mg/kg/day for 5 days 1

• Azithromycin is the preferred macrolide in this age group (lower risk of infantile hypertrophic pyloric stenosis compared to erythromycin)
• Monitor for IHPS and serious adverse events during treatment 1

Infants 1-5 Months

For pertussis: 10 mg/kg/day for 5 days 1

Infants and Children ≥6 Months

Standard respiratory infections (otitis media, sinusitis, pneumonia):

• 5-day regimen: 10 mg/kg (max 500 mg) on Day 1, then 5 mg/kg/day (max 250 mg) on Days 2-5 1, 3
• 3-day regimen: 10 mg/kg/day for 3 days 3
• Single-dose regimen for otitis media: 30 mg/kg as single dose 3

Pharyngitis/Tonsillitis (≥2 years):

• 12 mg/kg once daily for 5 days (max 500 mg/day) 3
• Higher dosing (60 mg/kg total course) shows superior eradication of Group A Streptococcus 4, 5
• The 60 mg/kg regimen can be given as either 12 mg/kg/day × 5 days or 20 mg/kg/day × 3 days 5

Adults

Community-acquired pneumonia, pharyngitis, skin infections:

• 500 mg on Day 1, then 250 mg daily on Days 2-5 3

Acute bacterial exacerbations of COPD:

• 500 mg daily for 3 days OR
• 500 mg Day 1, then 250 mg Days 2-5 3

Chlamydial infections (urethritis/cervicitis):

• Single 1 gram dose 6, 7
• Equally efficacious to doxycycline 100 mg BID × 7 days 6
• Preferred when compliance is questionable 6

Gonococcal infections:

• Single 2 gram dose 3
• Note: Not recommended as widespread first-line due to resistance concerns

Chancroid:

• Single 1 gram dose 3

Traveler's diarrhea with dysentery:

• Single 1 gram dose OR 500 mg daily × 3 days 8
• First-line for dysentery due to fluoroquinolone-resistant Campylobacter 8

Long-term therapy for bronchiectasis/asthma:

• 250-500 mg three times weekly 2
• Requires baseline ECG, liver function tests, and microbiological screening 2
• Minimum 6-12 months to assess efficacy 2

Special Populations

Pregnancy

FDA Pregnancy Category B 1

• Safe to use when indicated
• For chlamydia in pregnancy: 1 gram single dose 9
• Alternative: Amoxicillin 500 mg TID × 7 days 9

Renal Impairment

• No dose adjustment for GFR 10-80 mL/min 3
• Use with caution if GFR <10 mL/min (AUC increases 35%) 3

Elderly

No dose adjustment needed, though elderly women may have 30-50% higher peak concentrations 3

Common Pitfalls to Avoid

1. Underdosing streptococcal pharyngitis: Use 12 mg/kg/day × 5 days (60 mg/kg total), not the standard respiratory infection dose—lower doses have 3× higher bacterial failure rates 4, 5

2. Antacid timing: Never give antacids simultaneously—they significantly reduce absorption 1

3. Neonatal IHPS monitoring: When treating infants <1 month, counsel parents about pyloric stenosis signs (projectile vomiting) 1

4. Compliance advantage ignored: In populations with poor follow-up, azithromycin's single-dose or short-course regimens are more cost-effective than multi-day alternatives 6

5. Long-term use without monitoring: Chronic macrolide therapy requires baseline ECG, LFTs, and consideration of antimicrobial resistance development 2

Side Effects Profile

Most common (generally mild-moderate):

• Gastrointestinal: diarrhea (3.6%), abdominal pain (2.5%), nausea, vomiting 1, 10
• Headache, dizziness 1
• Overall side effect rate: 12% (lower than comparator antibiotics at 14.2%) 10
• Withdrawal rate: 0.7% (significantly lower than comparators at 2.6%) 10

Serious but rare:

• QT prolongation/dysrhythmias 8
• Cholestatic hepatitis 1
• Hearing loss (reversible) 1

Long-term use concerns:

• Antimicrobial resistance development (particularly erm(C) and msr(A) genes) 11
• Gastrointestinal dysbiosis 8

Administration Considerations

• Can be taken with or without food (except antacids) 3
• First dose should be directly observed when possible to maximize compliance 6
• Patients should abstain from sexual activity for 7 days after single-dose therapy for STIs 6